Objectives

After participating in this educational activity, attendees should be able to:
1. Review the drug development history of rilpivirine LA and cabotegravir tablets/LA
2. Discuss key questions and thems found in patient selection of oral vs long-acting ART
3. Report the data of LA-ART as PrEP

Faculty

Hans Schlecht, MD
Physician
Baystate Medical Center 

Faculty Disclosure

The design and content of Baystate Continuing Interprofessional Education ( CE ) activities support quality improvement in healthcare and provide fair and balanced views of therapeutic options.  Faculty or planner conflicts of interest are resolved before the educational activity.

None of the other members of the faculty and planning committee for this educational event have commercial relationships with any entity producing, marketing, re-selling or distributing health care goods and services consumed by or used on patients.

Session date: 
Thursday, January 7, 2021 - 12:00pm to 1:00pm
Location: 
Baystate Medical Center
759 Chestnut St.
Springfield, MA 01199
United States
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 ANCC Contact Hours
  • 1.00 BCIPE Instructional Hours

Please login or register to take this course.